Research findings (26, 27) highlight that activation of the NLRP3 inflammasome fosters the release of IL-1β and IL-18 from myocardial and arterial endothelial cells, ultimately causing coronary artery impairment and exacerbation of MI. Here, NLRP3 is linked to myocardial infarction.